Holcim (HOLN) Earnings: Recurring EBIT Rises to CHF1.44B Amidst Strategic Growth Initiatives

Holcim on Smartkarma

Analyst coverage of Holcim on Smartkarma indicates positive sentiment towards the company’s strategic move. In a report by Rahul Jain titled “Holcim (HOLN.SW) / Amrize (AMRZ): North America Spin-Off Unlocks Strategic and Valuation Upside,” the completion of the spin-off of Holcim’s North American business, Amrize, on June 23, 2025, is highlighted. Jain points out that this transaction allows Holcim to concentrate on global sustainable construction, while positioning Amrize to target the thriving U.S. infrastructure and housing markets. With a projected Enterprise Value of $30 billion, Amrize’s potential listing price near $54.43 per share implies a post-spin trading value of CHF 68.20 for Holcim.

A look at Holcim Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Holcim Ltd., a leading provider of building materials worldwide, seems to have a promising long-term outlook, according to Smartkarma Smart Scores. With strong scores in Dividend and Value indicators, the company appears well-positioned to provide good returns to its investors while also offering stable dividends. Moreover, its respectable Resilience score suggests that Holcim has the ability to weather economic uncertainties and market volatility, further enhancing its appeal as a long-term investment option.

Although Holcim’s Growth and Momentum scores are not as high as some of its other metrics, the overall positive trend in the Smart Scores indicates a sound foundation for the company’s future performance. Investors eyeing a reliable investment in the building materials sector may find Holcim to be a solid choice based on these Smart Scores and the company’s core focus on producing a range of essential construction materials.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma